✦ LIBER ✦

Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells

✍ Scribed by Yuki Nishimura-Sakurai; Naoya Sakamoto; Kaoru Mogushi; Satoshi Nagaie; Mina Nakagawa; Yasuhiro Itsui; Megumi Tasaka-Fujita; Yuko Onuki-Karakama; Goki Suda; Kako Mishima; Machi Yamamoto; Mayumi Ueyama; Yusuke Funaoka; Takako Watanabe; Seishin Azuma; Yuko Sekine-Osajima; Sei Kakinuma; Kiichiro Tsuchiya; Nobuyuki Enomoto; Hiroshi Tanaka; Mamoru Watanabe

Book ID: 106180587
Publisher: Springer Japan
Year: 2009
Tongue: English
Weight: 939 KB
Volume: 45
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-009-0162-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

661 COMPARISON OF HCV-ASSOCIATED GENE EX

661 COMPARISON OF HCV-ASSOCIATED GENE EXPRESSION AND CELL SIGNALING PATHWAYS IN CELLS WITH OR WITHOUT HCV REPLICON AND IN REPLICON-CURED CELLS

✍ Y. Nishimura-Sakurai; N. Sakamoto; K. Mogushi; S. Nagaie; M. Nakagawa; Y. Itsui; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Gene expression associated with interfer

Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line

✍ Haizhen Zhu; Hongshan Zhao; Christin D. Collins; Sarah E. Eckenrode; Qingguo Run 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB

30 Clearance and rebound kinetics of HCV

30 Clearance and rebound kinetics of HCV RNA in replicon cells treated with VX-950, a novel HCV NS34A protease inhibitor, alone or in combination with interferon alpha

✍ K. Lin; R.B. Perni; A.D. Kwong; C. Lin 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 55 KB

In Vitro Combination Therapy with Tegobu

In Vitro Combination Therapy with Tegobuvir (GS-9190) is Highly Efficient in Curing Cells from HCV Replicon and in Delaying/Preventing the Development of Antiviral Resistance

✍ Inge Vliegen; Jan Paeshuyse; I-hung Shih; Gerhard Pürstinger; Steven Bondy; Will 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 75 KB

482 IN VITRO COMBINATION THERAPY WITH TE

482 IN VITRO COMBINATION THERAPY WITH TEGOBUVIR (GS-9190) IS HIGHLY EFFICIENT IN CURING CELLS FROM HCV REPLICON AND IN DELAYING/PREVENTING THE DEVELOPMENT OF ANTIVIRAL RESISTANCE

✍ I. Vliegen; L. Delang; J. Paeshuyse; I.-H. Shih; G. Pürstinger; S. Bondy; W.A. L 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Effects of interferon on HCV and EMCV re

Effects of interferon on HCV and EMCV replication in the same cell line: Interferon inhibitory NS5A sequences do not inhibit the effects of IFN when expressed in the replicon

✍ J.A. Waters; M. Jones; M. Jacobs; P. Roberts; P. Karayiannis; H.C. Thomas; G.R. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 161 KB